Literature DB >> 32773465

Transport of LDLs into the arterial wall: impact in atherosclerosis.

Xinbo Zhang1,2, Carlos Fernández-Hernando1,2,3.   

Abstract

PURPOSE OF REVIEW: Atherosclerosis is a complicated cardiovascular disease characterized by unbalanced lipid metabolism and unresolved inflammation that occurred inside of arteries. The transcytosis of LDL across the endothelium and its accumulation in the arterial wall is the initial step of atherosclerosis. Here, we summarize recent research into the understanding of the regulatory mechanisms of endothelial LDL transcytosis and its relevance in the development of atherosclerosis. RECENT
FINDINGS: A number of recent studies have revealed the contribution of caveolae, activin-like kinase 1 (ALK1) or scavenger receptor B1 (SR-B1) in endothelial LDL transcytosis and the progression of atherosclerosis. Caveolin-1 (Cav-1), the major protein component in caveolae, is required for the formation of caveolae and caveolae-mediated LDL uptake and transcytosis across the endothelium. SR-B1 and ALK1 directly bind LDL and facilitate the transport of LDL through the endothelial cells. The change in expression of caveolae-associated proteins and SR-B1 regulates endothelial LDL transcytosis and the pathogenesis of atherosclerosis.
SUMMARY: Caveolae, ALK1 and SR-B1 are identified as key regulators in the LDL transcytosis across the endothelium. Endothelial LDL transcytosis might be a potential therapeutic approach to limit the initiation of early atherosclerosis and treat the atherosclerotic vascular diseases.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32773465      PMCID: PMC7951609          DOI: 10.1097/MOL.0000000000000701

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.616


  45 in total

Review 1.  Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities.

Authors:  Magnus Bäck; Arif Yurdagul; Ira Tabas; Katariina Öörni; Petri T Kovanen
Journal:  Nat Rev Cardiol       Date:  2019-07       Impact factor: 32.419

2.  Altered metabolism of LDL in the arterial wall precedes atherosclerosis regression.

Authors:  Emil D Bartels; Christina Christoffersen; Marie W Lindholm; Lars B Nielsen
Journal:  Circ Res       Date:  2015-09-10       Impact factor: 17.367

Review 3.  Macrophage Phenotype and Function in Different Stages of Atherosclerosis.

Authors:  Ira Tabas; Karin E Bornfeldt
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

4.  Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.

Authors:  Paolo Zanoni; Sumeet A Khetarpal; Daniel B Larach; William F Hancock-Cerutti; John S Millar; Marina Cuchel; Stephanie DerOhannessian; Anatol Kontush; Praveen Surendran; Danish Saleheen; Stella Trompet; J Wouter Jukema; Anton De Craen; Panos Deloukas; Naveed Sattar; Ian Ford; Chris Packard; Abdullah al Shafi Majumder; Dewan S Alam; Emanuele Di Angelantonio; Goncalo Abecasis; Rajiv Chowdhury; Jeanette Erdmann; Børge G Nordestgaard; Sune F Nielsen; Anne Tybjærg-Hansen; Ruth Frikke Schmidt; Kari Kuulasmaa; Dajiang J Liu; Markus Perola; Stefan Blankenberg; Veikko Salomaa; Satu Männistö; Philippe Amouyel; Dominique Arveiler; Jean Ferrieres; Martina Müller-Nurasyid; Marco Ferrario; Frank Kee; Cristen J Willer; Nilesh Samani; Heribert Schunkert; Adam S Butterworth; Joanna M M Howson; Gina M Peloso; Nathan O Stitziel; John Danesh; Sekar Kathiresan; Daniel J Rader
Journal:  Science       Date:  2016-03-11       Impact factor: 47.728

5.  Smallest LDL particles are most strongly related to coronary disease progression in men.

Authors:  Paul T Williams; H Robert Superko; William L Haskell; Edwin L Alderman; Patricia J Blanche; Laura Glines Holl; Ronald M Krauss
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

6.  A novel assay uncovers an unexpected role for SR-BI in LDL transcytosis.

Authors:  Susan M Armstrong; Michael G Sugiyama; Karen Y Y Fung; Yizhuo Gao; Changsen Wang; Andrew S Levy; Paymon Azizi; Mark Roufaiel; Su-Ning Zhu; Dante Neculai; Charles Yin; Steffen-Sebastian Bolz; Nabil G Seidah; Myron I Cybulsky; Bryan Heit; Warren L Lee
Journal:  Cardiovasc Res       Date:  2015-09-02       Impact factor: 10.787

7.  C-reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells.

Authors:  Fang Bian; Xiaoyan Yang; Fan Zhou; Pin-Hui Wu; Shasha Xing; Gao Xu; Wenjing Li; Jiangyang Chi; Changhan Ouyang; Yonghui Zhang; Bin Xiong; Yongsheng Li; Tao Zheng; Dan Wu; Xiaoqian Chen; Si Jin
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

8.  Role of caveolin-1 in the regulation of lipoprotein metabolism.

Authors:  Philippe G Frank; Stephanos Pavlides; Michelle W-C Cheung; Kristin Daumer; Michael P Lisanti
Journal:  Am J Physiol Cell Physiol       Date:  2008-05-28       Impact factor: 4.249

Review 9.  Diabetes and atherosclerosis: is there a role for hyperglycemia?

Authors:  Alan Chait; Karin E Bornfeldt
Journal:  J Lipid Res       Date:  2008-11-23       Impact factor: 5.922

10.  SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis.

Authors:  Chieko Mineo; Philip W Shaul; Linzhang Huang; Ken L Chambliss; Xiaofei Gao; Ivan S Yuhanna; Erica Behling-Kelly; Sonia Bergaya; Mohamed Ahmed; Peter Michaely; Kate Luby-Phelps; Anza Darehshouri; Lin Xu; Edward A Fisher; Woo-Ping Ge
Journal:  Nature       Date:  2019-04-24       Impact factor: 69.504

View more
  4 in total

Review 1.  Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia.

Authors:  Jan Borén; Marja-Riitta Taskinen; Elias Björnson; Chris J Packard
Journal:  Nat Rev Cardiol       Date:  2022-03-22       Impact factor: 49.421

Review 2.  Atherogenesis, Transcytosis, and the Transmural Cholesterol Flux: A Critical Review.

Authors:  Doron Goldberg; Soliman Khatib
Journal:  Oxid Med Cell Longev       Date:  2022-04-14       Impact factor: 7.310

3.  Functional characterization of nutraceuticals using spectral clustering: Centrality of caveolae-mediated endocytosis for management of nitric oxide and vitamin D deficiencies and atherosclerosis.

Authors:  Anton Franz Fliri; Shama Kajiji
Journal:  Front Nutr       Date:  2022-08-15

Review 4.  Pathophysiology of Atherosclerosis.

Authors:  Shifa Jebari-Benslaiman; Unai Galicia-García; Asier Larrea-Sebal; Javier Rekondo Olaetxea; Iraide Alloza; Koen Vandenbroeck; Asier Benito-Vicente; César Martín
Journal:  Int J Mol Sci       Date:  2022-03-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.